Health
Scientific Committees
Scientific Steering Committee (former MDSC)
Outcome of discussions
Minutes of the
Scientific Steering Committee Meeting of 13-14 April
2000
1. Welcome, apologies, introductory
remarks, declaration of interest in relation to the
current agenda
Prof.Dr.Pascal welcomed the
participants. He apologised, for the afternoon of 14 April,
Profs.W.Bridges and M.Gibney. He also welcomed Dr E.
Vanopdenbosch who would, on 13 April 2000, report on
several of the draft opinions prepared by the TSE/BSE
ad hoc Group. The list of participants is attached
as annex 1.
Declarations of interest:
No member declared an interest in any of
the items on the agenda of this specific meeting.
2. Approval of the agenda
The agenda was approved without changes.
It is attached as annex 2.
3. Approval of the minutes of the meeting of 2-3 March
2000.
The minutes of the meeting of 2-3 March
were adopted with changes. It was clarified that each
country for which the geographical BSE risk had been
assessed would only receive its own individual draft
report.
4. Multidisciplinary matters:
a. Emerging health issues
Prof.Bridges prepared a first draft
report on the basis of contributions from Profs. Pascal,
Klein, James, Hardy and Knudsen and on the basis of the
provisory list of emerging issues established at previous
SSC meetings. The document was discussed and the draft list
of possible emerging issues was amended. It is attached as
annex 3. The SSC confirmed again that this annex should
still be considered to be the result of a brainstorming. It
is not ranked in terms of priority or in any other way. The
SSC stressed that it is in no way to be considered as list
of priority public health concerns. Many other, and in many
cases more important, public health and consumer protection
issues do not figure on the list, for example because they
are being addressed already, because they are not a
"possibly emerging risk", because they are not within the
mandate of the SSC, etc. The principle of re-organising the
list into real possible emerging hazards and possible
re-emerging hazards was accepted. There was also a
consensus that a number of items would eventually have to
be deleted from the list.
A work distribution and work-plan were
agreed upon and it was decided that an updated document
would be further discussed and possibly adopted at the
meeting of 25-26 May 2000.
b. Emerging health issues: pilot exercise applied to
GMOs.
No further progress was made on this
issue. It will be further discussed at the next
meeting.
c. Harmonisation of risk assessment procedures
(progress report and discussion)
The Working Party on "Harmonisation of
Risk Assessment procedures" hold its third meeting on April
3, 2000 and discussed the following issues:
-
Priorities and timetable. Priority should be given
to addressing issues which relate directly to the
improvement of risk assessment across the nine DG Sanco
Scientific Committees and/or improve their ability to carry
out their mandates. The intention is to produce a report
for the SSC by mid September 2000 at the latest.
-
Form of the final report. It was agreed that the
report would consist of a main report with a number of
appendices. These would include the reports of the
sub-groups and of individual expert advisers.
-
Definitions. A set of working definitions has been
agreed. Members were further asked to identify
sub-definitions which are necessary to further explain a
particular use of terms in a risk factor specific
context.
-
Quantitative Risk Assessment. The work continues to
be focused on developing a strategy for introducing
quantitative risk assessment across the various Scientific
Committees. Based on a report produced by an individual
expert adviser, guidelines would be developed on when and
how should quantitative risk assessment be applied for
non-threshold and threshold chemicals. It was also agreed
to establish two working sub-groups to cover the issue of
quantitative risk assessment for microbiological hazards.
One would tackle with microbiological contamination of food
and other products, the other with infection spread (with
particular reference to imported animals).
-
Committee guidelines. The work is progressing in
three directions:
i) development of general guidelines for
hazard identification and hazard characterisation,
ii) establishment of a working sub-group
to develop general guidelines on exposure
assessment,
iii) harmonisation of presentation of
scientific opinions.
- Interface between risk assessors and risk
managers. The working party examined a draft proposal
for guidelines on the procedures to ensure effective and
efficient dialogue between risk assessors and risk
managers. It was agreed to develop the proposal, while
giving attention to the involvement of public interest
groups in phrasing questions to the scientific committees,
and to gaining back information from risk managers on the
usefulness of the scientific opinions provided by the
different scientific committees.
The next Working Group meetings have
been scheduled for 22 May and 5 July.
d. White paper on Food Safety .
Prof.Kroes presented the draft document
he prepared on the basis of the SSC's first in-depth
discussion on the
White Paper on Food Safety held on 2-3 March 2000.
The paper was very positively welcomed. Following
discussion, further amendments were introduced. The
scientists agreed with the Commission's approach to set up
an independent body, but strongly advocate to extend its
mandate beyond food safety alone to all public health
issues, including the safety of non-food products and
environmental issues. Amongst other recommendations (see
Annex N°4), they also recommended that sufficient human
resources should be allocated to the scientific
secretariats of the Food Safety Authority in order to
guarantee their optimal functioning.
David Byrne, Commissioner for Health and
Consumer Protection, attended part of the discussions and
made a presentation with as principal theme the future Food
Safety Authority. The Committee presented the broad lines
of its document and exchanged of views with David Byrne,
especially about the plans for a Food Safety Authority as
developed in the Commission's White paper on Food
Safety.
A final statement explaining the SSC
views on the matter was adopted after Commissioner Byrne
had left. It is attached as Annex N° 4.
e. Statement on the functioning of the EC's Scientific
Committees
No progress was made in this field.
Prof.Wierup will prepare an updated draft statement, to be
discussed at the next meeting.
5. Multidisciplinary matters relating to TSE/BSE
5.1. Report by the chairman of the TSE/BSE ad-hoc
group.
Prof.V.Silano reported briefly on the
meeting of the TSE/BSE ad hoc Group of 30 March 2000. All
items addressed by the group are further dealt with in
detail under point 5.2 of these minutes.
5.2. Reports on specific issues.
Note: In the course of its discussions on the
various SRM-related opinions hereafter, the SSC considered
that the opinion of December 1997 on Specified Risk
Materials (SRM), should be updated in the light of its
SRM-related opinions adopted since then.
a. Safety of ruminant blood
The report of the Working Group and the
draft opinion prepared by the TSE/BSE
ad hoc Group at its meeting of 30 March 2000, were
discussed in detail and amended. The opinion
The Safety of ruminant blood with respect to TSE
risks was adopted
. It is attached as Annex 5.
b. Handling and storage of possibly BSE contaminated
MBM
Prof.W.Bridges presented briefly the
first draft
Notes on the safe handling, transport and storage of MBM
and other bovine derived materials which may be
contaminated with BSE or other pathogens, he prepared
as agreed upon at the last SSC meeting. The report will now
further be finalised by a working group and the TSE/BSE a
d hoc Group. It is expected to be submitted for
adoption by the SSC at either the May or the July 2000
meeting.
c. The safety of UK bone-in beef
The report of the Working Group and the
draft opinion prepared by the TSE/BSE
ad hoc Group at its meeting of 30 March 2000, were
discussed in detail and amended. The
Opinion on the UK decision to lift the ban on the
consumption of meat on the bone was adopted. It is
attached as Annex 6.
d. Safety of bones: re-assessment of the safety with
respect to TSEs, of certain types of specified risk
materials in small ruminants.
The report of the Working Group and the
draft opinion prepared by the TSE/BSE
ad hoc Group at its meeting of 30 March 2000, were
discussed in detail and amended. The Opinion
Specified Risk Materials of Small Ruminants. (Follow-up
to the SSC opinion of 24-25 September 1998 on the Risk of
Infection of Sheep and Goats with BSE Agent) was
adopted. It is attached as Annex 7.
e. The safety of ruminant vertebral column for the
production of gelatine and tallow
The report of the Working Group and the
draft opinion prepared by the TSE/BSE
ad hoc Group at its meeting of 30 March 2000, were
discussed in detail and amended. The opinion
Quantitative Risk Assessment on the Use of the Vertebral
Column for the production of Gelatine and Tallow was
adopted. It is attached as Annex 8.
Regarding the report of the Working
Group it was decided to make it available as a pre-report
on Internet, for public comments until 10 June. Further
discussion and possible adoption by the SSC is then
expected for 6-7 July 2000, following possible further
discussion by the TSE/BSE
ad hoc Group at its meeting of 22 June 2000. The
Pre-report is attached as annex 9.
f. Human Exposure Limit Line
The Scientific Steering Committee (SSC)
adopted at its meeting of 2-3 March 2000 a Preliminary
Opinion on
Oral exposure of humans to the BSE agent: infective dose
and species barrier. The document was put on Internet
on 6 March 2000 and the international scientific community
was invited comment on its contents. Only two comments have
been received by the secretariat of the SSC:
These comments were discussed by the SSC
and amendments in the pre-opinions were introduced, as
shown in the final opinion and report in Annex 10.
The SSC noted that, in its comments, the
Meat and Livestock Commission (MLC) refers to cattle to
cattle transmission studies on brain material obtained from
affected cattle which have now been completed in the UK.
The results will be published later this year. These
studies seem to show that actual titres in cattle are
significantly lower that those calculated by the Committee
and it is therefore suggested that more reliance should be
placed on these actual titres and less on the calculation
of the titre in the Opinion.
The SSC invites the MLC and the research
institute(s) involved in this research to communicate these
results to the Committee. It will then, if appropriate,
amend the attached opinion.
g. Geographical risk: position paper and reports on
the risk assessments of Member States and Third
Countries.
The SSC secretariat reported on the
state of affairs. The reports on the geographical risk
assessments of Member States and Third Countries had been
finalised. Each of the Member States (except Greece that
did not submit a dossier) had received its individual
country report. The reports on the third countries were in
the process of being mailed. Comments and possible
additional information were expected to reach the
secretariat before 28 April (Member States) or 8 May 2000
(Third Countries).
On behalf of Prof.Silano, the
secretariat also presented the update of the overall
opinion ("Avis chapeau") on geographical BSE risk. Adoption
of the overall opinion is expected either as a separate
document at the SSC meeting of 25-26 May 2000 or together
with the individual country reports.
An updated planning was proposed and
agreed upon.
h. TSE and culling.
No progress on this issue was made since
the last SSC meeting, as priority was given to the
Geographical BSE Risk Assessment exercise and to the
preparation of the opinions related to the safety of
ruminant materials.
i. Origin of BSE.
No progress on this issue was made since
the last SSC meeting.
j. Criteria for diagnosis of clinical and pre-clinical
TSE disease in sheep and for differential biochemical
diagnosis of TSE agent strains (for opinion)
The report of the Working Group and the
draft opinion prepared by the TSE/BSE
ad hoc Group at its meeting of 30 March 2000, were
discussed in detail and amended. The Opinion on
The criteria for diagnosis of clinical and pre-clinical
TSE disease in sheep and for differential biochemical
diagnosis of TSE agent strains, was adopted. It is
attached as Annex 11.
k. GME protocol on TSE inactivation
This item was not discussed, due to a
lack of time.
6. Organisational matters.
No organisational matters were
discussed
7. Co-ordination: Reports of the Chairmen of the 8
Scientific Committees.
The chairmen of all Scientific
Committees provided written reports on the activities of
their committees since the last SSC meeting (2-3 March
2000; see annex 12)
8. Information by the Commission services on matters
related to consumer health.
Mr.Eric Poudellet, DG SANCO E.3.,
reported on the Commission proposals on (1) the application
of rapid BSE diagnosis tests in support of present BSE
surveillance systems and (2) the regulation of the use of
material presenting risks as regards transmissible
spongiform encephalopathies.
9. Any other business.
No other businesses were
discussed.
The meeting ended on Friday 14 April
2000, at 17h00.
The next meeting will be held in
Brussels, on 25-26 May 2000, starting at 10h00.
Annex 1: List of participants of the Scientific
Steering Committee meeting of 13-14 April 2000
List of presence
Members of the SSC
:
Prof. Georges Bories, Prof. James W.
Bridges (not present on 14 April 2000 afternoon), Prof.
Fulgencio Garrido Abellán (not present on 14 April 2000
afternoon), Prof. Michael Gibney, Prof. Anthony R. Hardy,
Prof. Philip T. James, Prof. Keith H.Jones, Prof. Fritz
H.Kemper, Prof. Werner Klein, Prof. Ib Knudsen, Prof.Robert
Kroes, Prof .Albert Osterhaus, Prof. Gérard Pascal, Prof.
Vittorio Silano, Prof. Marcel Vanbelle, Prof. Martin
Wierup, Dr Emmanuel Vanopdenbosch (Present on 13 April
2000)
Participants from the Commission:
DG ENV: B. Jensen
DG SANCO: B. Carsin, C. Berlingieri, G. Costa-David,
J. Crespo Arce, W. de Klerck, M. de Solà, C. Diez, A.
Fokkema, G. Fracchia, J.L. Jouve, J.Kreysa, G. Morrison, E.
Poudelet, J. Savio, A. Somogyi, A. Van Elst, J. Vergnettes,
P. Vossen, P. Wagstaffe, A. Wilhelm
Stagiaires: J. Côté, S. Gamsjäger, A.
Szklanna
Annex 2: Agenda of the Scientific Steering Committee
Meeting of 13-14 April 2000
1. Welcome, apologies, introductory
remarks, declaration of interest
2. Approval of the agenda
3. Approval of the minutes of the
meeting of 2-3 March 2000
4. Multidisciplinary matters:
a. "Considerations for the evolution of
scientific advice to address emerging health issues"
(progress report and discussion)
b. Possibly emerging fields of concern
with respect to health and consumer protection (further
discussion and amendments)
c. Harmonisation of risk assessment
procedures (progress report and discussion)
d. White paper on Food Safety
(discussion).
e. Statement on the functioning of the
EC's Scientific Committees (discussion and possible
adoption)
5. Multidisciplinary matters relating to
TSE/BSE
5.1. Report by the chairman of the
TSE/BSE ad-hoc group, including also the proposed planning
for:
5.2. Reports on specific issues:
Production systems and products.
a. Safety of ruminant blood (discussion
and possible adoption of an opinion)
b. Handling and storage of possibly BSE
contaminated MBM (discussion and possible adoption of an
opinion)
c. The safety of UK bone-in beef
(discussion and possible adoption of an opinion)
d. The safety of ruminant vertebral
column for the production of gelatine and tallow
(discussion and possible adoption of an opinion).
e. Safety of bones: re-assessment of the
safety with respect to TSEs, of certain types of specified
risk materails in small ruminants. (discussion and possible
adoption of an opinion)
Human exposure risk
f. "Human Exposure Limit Line"
(discussion of the comments received on the preliminary
opinion and possible adoption of a final opinion).
Geographical risk.
g. Geographical risk: position paper and
reports on the risk assessments of Member States and Third
Countries (further discussion).
h. TSE and culling (discussion).
i. Origin of BSE (progress
report).
Other TSE/BSE related issues:
j. criteria for diagnosis of clinical
and pre-clinical TSE disease in sheep and for differential
biochemical diagnosis of TSE agent strains (for
opinion)
k. GME protocol on TSE
inactivation
6. Organisational matters.
- Transparency regarding the membership
of working groups; guidelines.
7. Co-ordination: Reports of the
Chairmen of the 8 Scientific Committees.
8. Information by the Commission
services on matters related to consumer health.
9. Any other business.
Commissioner Byrne will attend the
meeting on Friday 14 April 2000, 12h30. The principal theme
of his presentation and of the discussion will be on the
future Food Safety Authority.
Annex 3:
Draft initial* list of possible fields for concern in
the medium-term future
(Updated listing as on 14.04.00)
Item
|
1.
Agents and media
|
a. Viruses (including
genetically modified viruses), prions
.
|
b. Antibiotic resistant
micro-organisms
(including new infections because of
antimicrobial resistance and/or because of increased
virulence of agents).
|
c.Natural toxins
(including "natural"medications),
including, amongst others, mycotoxins and toxins in
algae
;
|
d. Non-ionizing radiation
(including new claims on supposed
diseases ( re cancer) due to cellular
phones.
|
e. Climate change
, (including extreme weather
events and results of increased temperatures)
|
f. Macronutrient imbalance
and its direct and indirect
consequences for disease;
|
g. Industrial chemicals in the
environment
(including non communicable chronic
diseases, causes and prevention: role of industrial
chemical and chemical pollutants from food and
environment).
|
h. Physical and psychological
stress
|
i. Addictive substances
|
j. Urban terrorism using
chemical or biological agents
|
k. Gene therapy
; safety of vectors used in gene
therapies;
|
2.
Media for transmission
|
a. Drinking water (including
ground water),
(including Unexpected microbial
diseases linked with (drinking) water);
|
b. Blood transfusions
(including upcoming diseases due to
blood transfusion).
|
c. Xeno transplants
|
d. New processes of waste
treatment
, eg: recycling (including health hazards due to
the recycling of toxic substances for example when
recycling animal waste);
|
e. Indoor air
J
.
|
3.
Particular effects of concern
|
a. Endocrine disruption (human and
environmental)
(including environmental pollutants
and endocrine disrupters and their interference with
the immunosystem).
|
b. Allergenicit
y,
|
c. Behavioural changes
|
d. Special and protected
environments
|
e. Musculo-skeletal
damage
,
|
f. Synergy between
chemicals/chemicals and micro-organisms
, (with increased life expectancy
as an exacerbating factor).
|
4.
Methodology
|
a. Identification of susceptible
individuals / groups
,
|
b. Harmonisation of risk
assessment
,
|
c. Quantitative risk
assessment
(including Increase pression to
deliver quantitative estimates of risks involved with
(unexpected) exposures to agents (chemical, biological
and physical);
|
d. Sustainability
(Including: implementing the
sustainability principle across the various scientific
committees; its implications for risk assessment and
scientific advice).
|
e. Risk communication
, (Including scientific illiteracy
as a possible (emerging) (individual and public)
health hazard; including aspects such as risk
perception and risk communication).
|
f. improved testing methods (human
and environmental),
|
g. Use of human volunteers
(including: the need for a
world-wide acknowledgement and agreement on the use of
human (volunteers) in biological
experiments:
> amendments to the
"Declaration of Helsinki" (World Association of
medical Doctors)
> rules for participation of
humans in potential harmful trials (e.g., aiming the
immune system; intentional sensitisation; corrosivity
on the skin or mucous membranes;)
|
h. Better international
collaboration
(including: mutual recognition of
results in the same [above] fields of science and
regulatory/administrative acknowledgement (e.g., EC,
EU, Council of Europe, OECD, ...).
|
i. Improved monitoring and
surveillance systems for early detection of adverse
effects
(including?:better prediction of
harmful effects of chemicals and other products on
humans and the environment (e.g., carcinogenic
effects):
> support of appropriate
methodologies (R&D).
|
*
Note: This list should still be considered to be the
result of a brainstorming. It is not ranked in terms of
priority or in any other way. The SSC stresses that it is
in no way to be considered as list of priority public
health concerns. Many other, and in many cases more
important, public health and consumer protection issues do
not figure on the list, for example because they are being
addressed already, because they are not a "possibly
emerging risk", because they are not within the mandate of
the SSC, etc.
Annex 4: Integrated comments and remarks of the
Scientific Steering Committee (SSC) on the White Paper
for Food Safety adopted by the SSC at its meeting of
13-14 April 2000 (Distributed separately)
Annex 5: Opinion on The Safety of ruminant blood
with respect to TSE risks adopted by the Scientific
Steering Committee at its meeting of 13-14 April 2000
(Distributed separately)
Annex 6: Opinion on the UK decision to lift the
ban on the consumption of meat on the bone adopted by the
Scientific Steering Committee at its meeting of 13-14
April 2000 (Distributed separately)
Annex 7: Opinion of the Scientific Steering
Committee on specified risk materials of small ruminants.
(Follow-up to the SSC opinion of 24-25 September 1998 on
the Risk of Infection of Sheep and Goats with BSE
Agent) adopted at its meeting of 13-14 April 2000
(Distributed separately)
Annex 8: Opinion on Quantitative Risk Assessment
on the Use of the Vertebral Column for the production of
Gelatine and Tallow. Adopted by the Scientific Steering
Committee at its meeting of 13-14 April 2000 (Distributed
separately)
Annex 9: Preliminary Report on Quantitative Risk
Assessment on the Use of the Vertebral Column for the
production of Gelatine and Tallow. Submitted to the
Scientific Steering Committee at its meeting of 13-14
April 2000
THIS REPORT IS OPEN FOR
PUBLIC
COMMENTS UNTIL 10
JUNE 2000
Comments can be sent to:
Paul.vossen@ec.europa.eu
or:
joachim.kreysa@ec.europa.eu
Please pay special attention to
the assumptions made and to the proposed probability
distributions (including their key-values).
|
(Distributed separately)
Annex 10: Opinion Oral Exposure of Humans to the BSE
Agent : Infective dose and species barrier adopted by
the Scientific Steering Committee at its meeting of 13-14
April 2000 following a public consultation via Internet
between 6 and 27 March 2000 (Distributed
separately)
Annex 11: Report and Opinion on The criteria for
diagnosis of clinical and pre-clinical TSE disease in
sheep and for differential biochemical diagnosis of TSE
agent strains adopted by the Scientific Steering
Committee at its meeting of 13-14 April 2000 (Distributed
separately)
Annex 12: Reports from the secretariats of
Scientific Committees on the major activities and
milestones since the SSC meeting of 2-3 March
2000.
Scientific Committee for Plants
Scientific Committee on Animal Nutrition (SCAN)
Several groups met between 01 March and
15 April in order to prepare the plenary meeting of 27-28
April 2000.
Scientific Committee Veterinary Measures relating to
Public Health
Working groups continue their work. Two
of them finalised a draft report which was discussed for
adoption at the plenary meeting.
A report on food-borne zoonoses was
adopted on 12 April 2000. The Committee accepted the review
of its opinion on growth promoting hormones of 30 April
1999, subject to confirmation that the working group
supported the Rapporteur's amendments that took account of
the very recently received report from JECFA (Toxicological
evaluation of certain veterinary drug residues in food, WHO
Food additives Series 43, prepared by the 52nd meeting of
JECFA).
The Committee agreed to adopt the
opinion by a written procedure provided that no major
problems were raised by the working group.
Scientific Committee on Animal Health and Animal
Welfare
1. Meeting of the Committee 21 March 2000. At its
meeting on 21 March, the Committee adopted two major
reports:
a. Report on Possible Links between Paratuberculosis
in Animals and Crohn's Disease in man
b. Report on The Welfare of Chickens kept for Meat
Production.
Both reports were adopted unanimously by
the committee.
2. Working Group meetings
a The use of vaccination against avian influenza
This newly established WG had its first
meeting on 23 March. This item is urgent and of
significance because of the current outbreak of the disease
in Italy.
b The use of vaccination against bluetongue in the
current european context
This newly established WG had its first
meeting on 11 April. This item is urgent and of
significance because this vector borne disease was reported
in Greece and Bulgaria in 1999 and may, depending on
climatic conditions, reappear this year.
c The Welfare of Animals kept for fur production.
This working group met on 23 March. This
will be a major report and several meetings of the group
are liable to be necessary before the report is
completed.
d Report on Brucella melitensis in sheep
This working group met on 12 April 2000
to continue its work. This disease is of concern because of
both animal and public health aspects.
Scientific Committee for Toxicity, Ecotoxicity and
the Environment
Scientific Committee for Cosmetics and Non-Food
Products
Two Working Party meetings took place,
during which the following items were discussed :
1. Preservatives, Colorants & Fragrances :
The Committee initiated the 2
nd phase of their mandate on the review on the
safety of perfumery materials, namely to respond to the
question if they could agree that all materials that IFRA
(International Fragrance Association) recommend should not
be used as fragrance compounds are included in Annex II -
List of substances which must not form part of the
composition of cosmetic products - to Directive 76/768/EEC
on cosmetic products.
In the absence of specific regulations
for fragrances, IFRA introduced self-regulatory disciplines
for the industry, such as the IFRA list of prohibited
fragrance ingredients. This list, which is based primarily
on cutaneous safety concerns, was used as the basis for a
discussion.
Draft opinion on Lithium and Calcium
hydroxide : the WP approved this draft and addressed it to
the plenary for formal adoption. The draft opinion
specifies the 'other uses' of these substances in cosmetic
formulations (entries 15b and 15c of Annex III to the
cosmetics directive).
2. Inventory :
During the meeting it was possible to
reach a final agreement on the modifications concerning
issues such as the chemical identity of problematic
ingredients, functions, the improvement of the
identification of botanical ingredients, which should be
integrated in the first Update of the Inventory of cosmetic
ingredients. It is planned to adopt the revised document in
June 2000.
Scientific Committee for Medicinal Products and
Medical Devices
[
©]
- [
HEALTH] - [
SCIENTIFIC COMMITTEES] - [
SCIENTIFIC STEERING COMMITTEE] -
[
OUTCOME OF DISCUSSIONS]
|